Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC -Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa
JCO Global Oncology · 2025-01 · (11)
DOI: 10.1200/go.24.00210 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2025-01. Verfasst von Clara Chamba und 17 weiteren Autor:innen. Beteiligte Einrichtung: Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Burkitt Lymphoma, High-Throughput Nucleotide Sequencing, Herpesvirus 4, Human, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Epstein-Barr virus (EBV)–positive Burkitt lymphoma (BL) affects children in sub-Saharan Africa, but diagnosis via tissue biopsy is challenging. We explored a liquid biopsy approach using targeted next-generation sequencing to detect the MYC -immunoglobulin ( MYC -Ig) translocation and EBV DNA, assessing its potential for minimally invasive BL diagnosis. MATERIALS AND METHODS The panel included targets for the characteristic MYC -Ig translocation, mutations in intron 1 of MYC , mutations in exon 2 of MYC , and three EBV genes: EBV-encoded RNA (EBER)1, EBER2, and EBV nuclear antigen 2. It was first tested in a small derivation cohort of four precharacterized BL-derived cell lines with known translocation status and eight precharacterized plasma samples with known EBV DNA status by quantitative polymerase chain reaction (qPCR). These different data modalities were combined to assess the accuracy of this approach in the diagnosis of BL in 20 patient plasma samples in Tanzania and Uganda. RESULTS The next-generation sequencing panel detected three of four MYC -Ig translocations in the BL-derived cell lines. EBV viral load by targeted sequencing correlated strongly with qPCR results (Spearman's rho = 0.94) in precharacterized plasma samples. Using the patient plasma samples, mutations in MYC intron 1 were associated with the presence of a MYC translocation with 25 or more mutations being predictive of a translocation with AUC, sensitivity, and specificity of 1. Overall, liquid biopsy parameters associated with a diagnosis of BL ( P < .05) included cell-free DNA concentration, circulating tumor DNA concentration, MYC intron 1 mutations, MYC -Ig translocation, and autosome entropy. Integrating these parameters into a diagnostic model demonstrated excellent performance with an AUC of 0.95, sensitivity of 0.9, and specificity of 1. CONCLUSION This analysis demonstrates the potential of liquid biopsy to improve BL diagnosis in settings with limited pathology resources. Validation of our approach in a larger data set is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- University of Oxford, Oxford, United Kingdom.
- Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
- Muhimbili National Hospital, Dar es Salaam, Tanzania.
- St Mary's Lacor Hospital, Lacor, Uganda.
- Bugando Medical Centre, Mwanza, Tanzania.
ORCID-Profile: Clara Chamba, Kieran Howard, Helene Dreau, Adam Burns, William Mawalla, Priscus Mapendo, Ismail Legason, Edrick Elias, Caroline Achola, Anna Schuh
Zitieren
APA
Chamba, C., Jennings, D., Shungu, R., Christopher, H., Josephat, E., Howard, K., Dreau, H., Burns, A., Mawalla, W., Mapendo, P., Mnango, L., Legason, I., Elias, E., Achola, C., Cutts, A., Balandya, E., Schuh, A., & AI-REAL Consortium (2025). Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC -Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa. JCO Global Oncology. https://doi.org/10.1200/go.24.00210
Vancouver
Chamba C, Jennings D, Shungu R, Christopher H, Josephat E, Howard K, et al. Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC -Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa. JCO Global Oncology. 2025. doi:10.1200/go.24.00210
BibTeX
@article{Chamba2025,
author = {Chamba, Clara and Jennings, Daisy and Shungu, Rehema and Christopher, Heavenlight and Josephat, Emmanuel and Howard, Kieran and Dreau, Helene and Burns, Adam and Mawalla, William and Mapendo, Priscus and Mnango, Leah and Legason, Ismail and Elias, Edrick and Achola, Caroline and Cutts, Anthony and Balandya, Emmanuel and Schuh, Anna and AI-REAL Consortium, AI-REAL Consortium},
title = {Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC -Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa},
journal = {JCO Global Oncology},
year = {2025},
number = {11},
doi = {10.1200/go.24.00210}
}
EUVIMED